Right insights.
Right channels.
Every relevant stakeholder.

Our omnichannel medical communications make oncology and hematology clinical innovations relevant and impactful for healthcare professionals, payers, and patients.

TRM Oncology

A medical communications agency, by the numbers

We have some of the brightest minds in oncology and hematology medical communications. Our global resources, strategic programs, and longstanding relationships with key scientific leaders provide our life science partners with future-focused, evidence-based solutions – all designed to improve clinical decision making and enhance patient outcomes. View our Facts & Figures Infographic.

Education Icon

55+

Team members with unmatched expertise

Research Icon

15+

Therapeutic areas supported

Bottle Icon

2/3

Of all new oncology drugs supported in the last 3 years

Global Reach Icon

550+

Worldwide projects completed annually

Are you ready to explore new ideas?

Learn the many ways TRM Oncology can support you and your valued stakeholders.

All fields required

The power of evidence-based, omnichannel innovation

D3

Helping our partners successfully navigate the complex oncology and hematology marketplace is a critical part of what we do best. That’s why we created D3 – our unique, 3-phase approach provides competitive solutions to your most difficult challenges, every time.

1We Discover the insights that will have the greatest impact on the relevant stakeholders in your market

2We Develop creative, customized solutions that precisely target each insight and stakeholder

3We Deliver each insight to the right stakeholder through the right mix of relevant channels

We partner with the world’s best

AstraZeneca

Bayer

Lilly

Merck

Merck KGAa

Novartis

Roche

Pfizer

TRM icon

Up-to-date stories, articles, and insights from the TRM Oncology team

July 18th, 2018
4 Oncology Insights You Can Gain From Conference Coverage Reports

For pharma, an oncology conference is an important opportunity to inform and engage healthcare providers on the newest knowledge, with the motivation to improve patient outcomes and improve adherence.

Read more
July 11th, 2018
Inspiring Change in HCP Behavior Through Educational Interaction

Changes to patient-centric care require first and foremost the participation of healthcare professionals (HCPs), who have a huge impact on quality health practices.

Read more
July 5th, 2018
The various types of opinion leaders: What’s in a name?

As one of the highest priorities of pharma marketers, engaging with industry leaders is a crucial strategic exercise. Findings from an online survey in 2015 revealed that 62% of medical experts believe that the term “KOL” should be replaced. Yet coming up with an alternative is a challenge.

Read more

Want to learn more about TRM Oncology? We’d love to talk with you.

Contact Us